Skip to main content
. 2022 Aug 9;269(12):6467–6475. doi: 10.1007/s00415-022-11309-2

Table 2.

Univariate and multivariate comparisons between patients with delirium and patients without delirium

DLR + (n = 31) DLR − (n = 72) Effect variable Unadjusted value (95% CI) p Adjusted value (95% CI) p Pearson (p) Deviance (p) F-test Hosmer–Lemeshow (p) Nagelkerke (R2)
Primary outcome
 mRS at 90-days median (IQR) 4 (3–6) 1 (1–3) Odds ratio 6.80 (3.00–15.42) p < 0.001 4.83 (1.88–12.35) p = 0.006 p = 0.648 p = 1.00
Secondary outcomes
 Length of hospitalization median (IQR) 12 (8–16) 7 (5–8) Beta 7.15 (2.73–11.57) p = 0.002 3.73 (1.27–6.19) p = 0.003 p = 0.032
 mRS 0–1 at 90 days—n (%) 3 (10%) 38 (53%) Odds ratio 10.43 (2.91–37.42) p < 0.001 12.93 (2.50–66.96) p = 0.002 p = 0.629 0.436
 mRS 0–2 at 90 days—n (%) 7 (23%) 49 (68%) Odds ratio 7.30 (2.75–19.40) p < 0.001 5.93 (1.73–20.33) p = 0.005 p = 0.707 0.438
 mRS 0–3 at 90 days—n (%) 12 (39%) 57 (79%) Odds ratio 6.02 (2.40–15.09) p < 0.001 4.78 (1.39–16.45) p = 0.013 p = 0.860 0.406
 Death—mRS 6 at 90 days—n (%) 9 (29%) 6 (8%) Odds ratio 4.5 (1.44–14.07) p = 0.010 3.45 (0.66–17.95) p = 0.142 p = 0.001 0.409

The covariates considered in the adjusted analysis were: age, pre-event mRS, NIHSS at onset, atrial fibrillation, diabetes mellitus, hypertension, and heart diseases

Abbreviations: mRS modified Rankin Scale, IQR interquartile range, DLR + patients with delirium, DLR– patients without delirium